Elotuzumab
M22514
Product group Antibodies
Overview
- SupplierAbMole BioScience
- Product NameElotuzumab
- Delivery Days Customer9
- Category SupplierAntibody
- CertificationResearch Use Only
- Scientific DescriptionElotuzumab is a First-in-Class monoclonal antibody directed against the SLAMF7 receptor, it specifically binds to signaling lymphocyte activating molecule family member 7 (SLAMF7) and activates the body's immune response to attack and kill multiple myeloma cells. Elotuzumab exerts its anti-myeloma effects mainly through ADCC and activation of NK cells.
- Storage InstructionStore at -80°C
- UNSPSC12352203